Dana-Farber Cancer Institute oncologist Sara Tolaney, MD, MPH, explains treatment options for HR+/HER2- metastatic breast cancer, including aromatase inhibitors and CDK4/6 inhibitors.See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.

Dana-Farber Cancer Institute oncologist Sara Tolaney, MD, MPH, explains treatment options for HR+/HER2- metastatic breast cancer, including aromatase inhibitors and CDK4/6 inhibitors. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dana-Farber Cancer Institute oncologist Sara Tolaney, MD, MPH, explains treatment options for HR+/HER2- metastatic breast cancer, including aromatase inhibitors and CDK4/6 inhibitors.See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer">https://art19.com/privacy#do-not-sell-my-info</a>.

Exploring Your Treatment Options

In this series, we bring together the foremost medical experts to enlighten and empower women facing a diagnosis of HR+/HER2- metastatic breast cancer. They provide answers to your top questions and share insights and practical tips that help you move ahead with clarity and confidence.

Medicine

Health & Fitness

Nutrition

In this series, we bring together the foremost medical experts to enlighten and empower women facing a diagnosis of HR+/HER2- metastatic breast cancer. They provide answers to your top questions and share insights and practical tips that help you move ahead with clarity and confidence.

Share Exploring Your Treatment Options

Sign up to save your podcasts

Exploring Your Treatment Options

Exploring Your Treatment Options